Suchergebnisse - "Psychotic Disorders/diagnosis"

  1. 1
  2. 2
  3. 3

    Quelle: J Neurol
    Journal of neurology 271(12), 7402-7421 (2024). doi:10.1007/s00415-024-12576-x

    Schlagwörter: therapy [Parkinson Disease], etiology [Delirium], etiology [Disruptive, Impulse Control, and Conduct Disorders], administration & dosage [Antiparkinson Agents], Impulse control disorder, Review, diagnosis [Disruptive, Impulse Control, and Conduct Disorders], Guideline, Antiparkinson Agents, Germany, therapy [Psychotic Disorders], standards [Societies, Medical], Humans, ddc:610, therapy [Delirium], Societies, Medical, therapeutic use [Antiparkinson Agents], diagnosis [Delirium], etiology [Psychotic Disorders], Delirium, Parkinson Disease, Psychosis, drug therapy [Psychotic Disorders], 3. Good health, Disruptive, Impulse Control, and Conduct Disorders, Psychotic Disorders, Neurology, therapy [Disruptive, Impulse Control, and Conduct Disorders], standards [Neurology], standards [Practice Guidelines as Topic], Practice Guidelines as Topic, Parkinson's disease, diagnosis [Psychotic Disorders], Delirium/diagnosis [MeSH], Parkinson Disease/complications [MeSH], Psychotic Disorders/etiology [MeSH], Antiparkinson Agents/administration, Practice Guidelines as Topic/standards [MeSH], Psychotic Disorders/drug therapy [MeSH], Psychotic Disorders/therapy [MeSH], Neurology/standards [MeSH], Disruptive, Impulse Control, and Conduct Disorders/etiology [MeSH], Antiparkinson Agents/therapeutic use [MeSH], Humans [MeSH], Disruptive, Impulse Control, and Conduct Disorders/diagnosis [MeSH], Parkinson Disease/therapy [MeSH], Disruptive, Impulse Control, and Conduct Disorders/therapy [MeSH], Parkinson Disease/diagnosis [MeSH], Societies, Medical/standards [MeSH], Psychotic Disorders/diagnosis [MeSH], Germany [MeSH], Delirium/therapy [MeSH], Delirium/etiology [MeSH], complications [Parkinson Disease], diagnosis [Parkinson Disease]

    Dateibeschreibung: application/pdf

  4. 4

    Schlagwörter: Developmental psychology, Mental processes, Neuropharmacology/education, History of literature, Social psychology, Dissociative Disorders/physiopathology, Mental Processes, Sociology/methods, Sociology/education, Sociology, Cognitive psychology, Psychotic Disorders/classification, Psychology, Cognitive Neuroscience/methods, Social Communication Disorder, Empathy/genetics, Depression, Sociology/history, Mental Disorders, Communication, Communication Barriers, Neuropharmacology/classification, Literature/history, Depression/genetics, Political power, FOS: Sociology, Cognitive Neuroscience/ethics, FOS: Psychology, Psychotic Disorders/immunology, Mental Health, Environmental law, Dissociative Disorders/blood, Depression/complications, Political communication, Depression, Chemical, Communication policy, Communication Disorders, Psychotic Disorders/complications, Panic Disorder, Sociology/classification, Comparative law, Neuropharmacology/standards, Empathy/physiology, Cognitive Dissonance, Personality, Personality Disorders/metabolism, Affective Disorders, Psychotic, Personality Disorders/classification, Cognitive Neuroscience, Mental Disorders/economics, Mental Healing, Cognitive Reflection, Sociology, Medical/history, Dissociative Disorders, Molecular neuroscience, Personality Disorders, Gray Literature, Neuropharmacology, Neurosciences/education, Depression/diagnosis, Personality/genetics, Mental effect, Empathy/ethics, Psychotic Disorders/metabolism, Nonverbal Communication, Literature studies, FOS: Clinical medicine, Political doctrine, Neurosciences, Cognitive Psychology, Cognitive neuroscience, Personality Disorders/psychology, Neurosciences/ethics, Psychotic Disorders/psychology, Public law, Scholarly Communication, Environmental Psychology, Personality Development, Political philosophy, Political ideology, Psychotic Disorders, Literature, Dissociative Disorders/diagnosis, Mental Recall, Anesthetics, Dissociative/analysis, Cognitive Science, Interdisciplinary Communication, Psychiatry in Literature, Empathy, Sociology/standards, Psychotic Disorders/diagnosis, Depression/psychology

  5. 5
  6. 6
  7. 7
  8. 8

    Autoren: Arribas, M Oliver, D Patel, R et al.

    Weitere Verfasser: Arribas, M Oliver, D Patel, R et al.

    Quelle: Int J Neuropsychopharmacol
    Mol Psychiatry
    Arribas, M, Oliver, D, Patel, R, Kornblum, D, Shetty, H, Damiani, S, Krakowski, K, Provenzani, U, Stahl, D, Koutsouleris, N, McGuire, P & Fusar-Poli, P 2024, ' A transdiagnostic prodrome for severe mental disorders : an electronic health record study ', Molecular Psychiatry, vol. 29, no. 11, pp. 3305-3315 . https://doi.org/10.1038/s41380-024-02533-5

    Dateibeschreibung: application/pdf

  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Quelle: Schizophr Res
    RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
    instname
    Schizophrenia research, vol. 250, pp. 1-9
    Smart, S E, Agbedjro, D, Pardiñas, A F, Ajnakina, O, Alameda, L, Andreassen, O A, Barnes, T R E, Berardi, D, Camporesi, S, Cleusix, M, Conus, P, Crespo-Facorro, B, D'Andrea, G, Demjaha, A, Di Forti, M, Do, K, Doody, G, Eap, C B, Ferchiou, A, Guidi, L, Homman, L, Jenni, R, Joyce, E, Kassoumeri, L, Lastrina, O, Melle, I, Morgan, C, O'Neill, F A, Pignon, B, Restellini, R, Richard, J-R, Simonsen, C, Španiel, F, Szöke, A, Tarricone, I, Tortelli, A, Üçok, A, Vázquez-Bourgon, J, Murray, R M, Walters, J T R, Stahl, D & MacCabe, J H 2022, 'Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium', Schizophrenia research, vol. 250, pp. 1-9. https://doi.org/10.1016/j.schres.2022.09.009

    Dateibeschreibung: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

  18. 18
  19. 19
  20. 20